Article information
Full text is only aviable in PDF
Bibliografía
[1.]
R. Andre, H. Rochant, B. Dreyfus, et al.
Fibrose interstitielle diffuse du paumon au cours d’une maladie de Hodgkin traitee par des doses elevees d’endoxan.
Bull Soc Med Hop (París), 118 (1957), pp. 1.133-1.141
[2.]
J.A.D. Cooper Jr., D.A. White, R.A. Matthay.
Drug-induced pulmonary disease.
Am Rev RespirDis, 133 (1986), pp. 321-340
[3.]
J.I. Spector, H. Zimbler, J.S. Ross.
Early-onset cyclophosphamide induced interstitial pneumonitis.
JAMA, 242 (1979), pp. 2.852-2.853
[4.]
A.A. Topilaw, S.P. Rothenberg, T.S. Cottrell.
Interstitial pneumonia after prolonged treatment with cyclophosphamide.
Am Rev Respir Dis, 108 (1973), pp. 114-117
[5.]
C. Collins, J. Mortimer, R.B. Livingstone.
High-dose cyclophosphamide in the treatment of refractory lymphomas and solid tumor malignancies.
Cancer, 63 (1989), pp. 227-232
[6.]
K.J. Twohig, R.A. Matthay.
Pulmonary effects of cytotoxic agents other than bleomycin.
Clin Chest Med, 11 (1990), pp. 31-54
[7.]
S.W. Malik, J.L. Myers, R.A. DeRemee, U. Specks.
Lung toxicity associated with cyclophosphamide use: two distinct patterns.
Am J Respir Crit Care Med, 154 (1996), pp. 1.851-1.856
Copyright © 1999. Sociedad Española de Neumología y Cirugía Torácica
